DanielSprattMD

Radiation Oncology • Cleveland, OH

Central Nervous System Cancer, Urologic Cancer

Physician

Join to view full profile

Dr. Spratt is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Spratt's full profile

Already have an account?

Office
11100 Euclid Ave
Cleveland, OH 44106
Phone+1 216-844-1700

Fax+1 216-286-3989

Summary

Dr. Daniel Spratt is a radiation oncologist in Cleveland, OH and is affiliated with UH Cleveland Medical Center. He received his medical degree from Vanderbilt University School of Medicine and has been in practice 10 years. He specializes in urologic cancer and is experienced in prostate cancer.

Education & Training

Memorial Sloan Kettering Cancer CenterResidency, Radiation Oncology, 2011 - 2015
Spartanburg Medical CenterInternship, Transitional Year, 2010 - 2011
Vanderbilt University School of MedicineClass of 2010

Certifications & Licensure

OH State Medical License 2021 - 2025
MI State Medical License 2015 - 2022
NY State Medical License 2011 - 2016
SC State Medical License 2010 - 2011
American Board of Radiology Radiation Oncology

Clinical Trials

A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer Start of enrollment: 2020 Nov 06
Recruiting
Phase 1, Phase 2

Publications & Presentations

PubMed

1 citations
Testosterone Recovery Following Androgen Suppression and Prostate Radiotherapy (TRANSPORT): A Pooled Analysis of Five Randomized Trials from the Meta-Analysis of Rando...
Wee Loon Ong, Tahmineh Romero, Soumyajit Roy, John Nikitas, David Joseph
European Urology. 2025-01-01
Prognostic factors in post-prostatectomy salvage radiotherapy setting with and without hormonotherapy: An individual patient data analysis of randomized trials from IC...
Pascal Pommier, Wanling Xie, Praful Ravi, Christian Carrie, James J Dignam
Radiotherapy and Oncology. 2024-12-01
Erratum to: Spratt DE, Liu VYT, Michalski J, Davicioni E, Berlin A, Simko JP, Efstathiou JA, Tran PT, Sandler HM, Hall WA, Thompson DJS, Parliament MB, Dayes IS, Corre...
Daniel E Spratt, Vinnie Y T Liu, Jeff Michalski, Elai Davicioni, Alejandro Berlin
International Journal of Radiation Oncology, Biology, Physics. 2024-12-01

Press Mentions

Radioligand Shows Promise in Metastatic Hormone-Sensitive Prostate CancerOctober 16th, 2024
No Benefit for PD-1 Inhibitors in Certain Gastroesophageal Cancers, FDA Panel SaysSeptember 27th, 2024
FDA’s ODAC Votes for New Requirements Due to Overtreatment Concerns in NSCLCJuly 29th, 2024
Join now to see all